60 Day FRN

28552

Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices

Background and Brief Description
CDC is requesting a three-year
Extension for the Generic ICR titled
Generic Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery. During the past three-year
approval period, CDC has submitted
eight GenICs consisting of 750
responses. The collections included
web-based surveys, focus groups, and
assessments. The information collection
activities conducted under this
extension will continue to garner
qualitative customer and stakeholder
feedback in an efficient, timely manner,
in accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide

an early warning of issues with service,
or focus attention on areas where
communication, training, or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative,
and actionable communications
between CDC and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this Generic
Clearance will continue to provide
useful information, but it will not yield
data that can be generalized to the
overall population. This type of Generic
Clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: (1)
the target population to which
generalizations will be made; (2) the

sampling frame; (3) the sample design
(including stratification and clustering);
(4) the precision requirements or power
calculations that justify the proposed
sample size; (5) the expected response
rate; (6) methods for assessing potential
non-response bias; (7) the protocols for
data collection; and 8) any testing
procedures that were or will be
undertaken prior fielding the study.
Depending on the degree of influence
the results are likely to have, such
collections may still be eligible for
submission for other Generic
mechanisms that are designed to yield
quantitative results.
Respondents will be screened and
selected from Individuals and
Households, Businesses, Organizations,
and/or State, Local or Tribal
Government. Below we provide CDC’s
projected annualized estimate for the
next three years. There is no cost to
respondents other than their time. The
estimated annualized burden hours for
this data collection activity are 9,690.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of collection

Individuals and Households, Businesses, Organizations, and/or State, Local or Tribal
Government.

Online surveys ...............................................
Discussion Groups .........................................
Focus groups .................................................
Website/app usability testing .........................
Interviews .......................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–09518 Filed 5–3–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–1359; Docket No. CDC–2023–
0034]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
ddrumheller on DSK120RN23PROD with NOTICES1

Number of
respondents

Type of respondent

CDC must receive written
comments on or before July 3, 2023.

DATES:

Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of

SUMMARY:

VerDate Sep<11>2014

17:12 May 03, 2023

Jkt 259001

government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National Survey
of Syringe Services Programs (NSSSP).
This data collection which proposes
assess and monitor SSP operational
characteristics and services, funding
resources, community relations, and key
operational and programmatic successes
and challenges, and support timely
analysis and dissemination of national
program evaluation survey findings.

You may submit comments,
identified by Docket No. CDC–2021–
0034 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600

ADDRESSES:

PO 00000

Frm 00094

Fmt 4703

Sfmt 4703

10,500
280
640
2,000
800

Annual
frequency
per response
1
1
1
1
1

Hours per
response
30/60
120/60
120/60
30/60
120/60

Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also

E:\FR\FM\04MYN1.SGM

04MYN1

28553

Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
The National Survey of Syringe
Services Programs (NSSSP) (OMB
Control No. 0920–1359, Exp. 12/31/
2024)—Revision—National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention, Centers

for Disease Control and Prevention
(CDC).
Background and Brief Description
The primary purpose of the National
Survey of Syringe Services Programs
(NSSSP) is to strengthen and improve
the ability of CDC and local and state
partners to monitor and evaluate syringe
services programs (SSPs) nationally,
with the overall goal of supporting,
sustaining, and improving SSPs
nationwide and reducing infectious
disease and other harms related to drug
use. Findings from the 2020–2021
survey successfully characterized
operational characteristics and services,
funding resources, community relations,
and key operational successes and
challenges. The 2022 survey is currently
being implemented. Revisions are being
requested to address the increasing
number of SSPs nationwide, the
changing landscape of drug use
nationally, additional SSP supplies and
services provided, and ways in which
SSPs are developing strategies to
address the needs of PWUD.
The project will include all SSPs that
are listed in a publicly available
directory of all known SSPs in the
United States maintained by the North
American Syringe Exchange Network
(NASEN; https://nasen.org). The project
will also include SSPs in NASEN’s
directory that do not wish to be publicly
listed but have agreed to be contacted
for research purposes, SSPs belonging to
NASEN’s buyers’ club that are not part
of the directory, respondents to prior
RTI Arnold Ventures Surveys of SSPs
that are not part of NASEN’s directory,
and other SSPs proactively identified
through searching state health
department websites, funding agencies,
state and regional networks, regional
conferences, partner organization

networks or webinars and via social
media. SSPs will be sent a letter of
invitation to participate in a 35-minute
program survey. Participating programs
will have the option of completing the
survey via different modalities to
enhance feasibility and comfort in
completing the survey, for example via
the Research Electronic Data Capture
(REDCap) or a similarly secure webbased application. Other modalities for
survey administration will include a
coordinated telephone or
videoconferencing interview. SSPs will
be sent reminder letters for an
approximately six-month data collection
period. SSPs that do not respond to
prior reminders will be sent one final
reminder, and if the SSP still does not
want to participate, one (optional)
question on why the SSP did not
complete the survey will be offered. The
survey will include questions on
operational characteristics and services,
funding resources, community relations,
and key operational successes and
challenges.
Approximately 800 SSPs will be able
to participate in the survey. We
anticipate that approximately 20% of
SSPs will decline to complete the
survey, yielding approximately 640
completed surveys per year. However,
given that it is challenging to predict
future response rates, we are requesting
enough burden hours to allow 100% of
SSPs to respond to the survey. We
estimate that it will take 35 minutes to
complete the survey, regardless of how
the respondent chooses to complete it
(i.e., self-administered online or
interviewer-administered by phone or
videoconferencing).
CDC requests OMB approval for an
estimated 494 annual burden hours.
There is no cost to respondents other
than their time to participate.

ESTIMATES OF ANNUALIZED BURDEN HOURS

ddrumheller on DSK120RN23PROD with NOTICES1

All participating SSPs .......................

800

1

35/60

467

Non-responding SSPs ......................

National Syringe Services Program
Evaluation Survey.
Non-Response Survey Item .............

800

1

2/60

27

Total ...........................................

...........................................................

........................

........................

........................

494

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–09519 Filed 5–3–23; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:12 May 03, 2023

Jkt 259001

PO 00000

Frm 00095

Fmt 4703

Sfmt 9990

E:\FR\FM\04MYN1.SGM

04MYN1